M4MM

Trump Fast Tracks Psychedelic Research

WASHINGTON D.C- President Donald Trump has signed a sweeping executive order to accelerate psychedelic research and expand patient access across the United States—marking one of the most significant federal policy shifts the sector has seen ...

Decibel Reports Q4 and FY 2025 Financial Results

CALGARY – Decibel Cannabis Company Inc. posted audited results for the fourth quarter and full year ended December 31, 2025, showing overall revenue growth driven largely by its international operations. Net revenue for the year ...

WM Technology to Delist from Nasdaq

IRVINE – WM Technology, Inc., the company behind the Weedmaps online Cannabis marketplace, announced that it will voluntarily pull its Class A common stock and warrants from the Nasdaq Global Select Market. The move comes ...

Trump Fast Tracks Psychedelic Research

WASHINGTON D.C- President Donald Trump has signed a sweeping executive order to accelerate psychedelic research and expand patient access across the United States—marking one of the most significant federal policy shifts the sector has seen ...

Decibel Reports Q4 and FY 2025 Financial Results

CALGARY – Decibel Cannabis Company Inc. posted audited results for the fourth quarter and full year ended December 31, 2025, showing overall revenue growth driven largely by its international operations. Net revenue for the year ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...

California Allocates $30M in Cannabis Research Grants

SACRAMENTO – California's Department of Cannabis Control has disbursed nearly $30 million to support 22 academic projects examining Cannabis's influence on public health, environmental practices, and the regulated market. The funding, drawn from taxes on ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

Subscribe To Our Newsletter